Cefazolin Pharmacokinetics: Elimination Clearance in Neonates
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To document cefazolin disposition (concentration/time profile, protein binding, metabolism,
renal elimination characteristics) and its covariates in neonates following intravenous
administration of the drug at induction of anesthesia, prior to an invasive procedure
To evaluate if optimalisation of cefazolin dose regimen during neonatal life is needed